Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis

ClinicalTrials.gov ID: NCT03129100

Public ClinicalTrials.gov record NCT03129100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis

Study identification

NCT ID
NCT03129100
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
773 participants

Conditions and interventions

Interventions

  • Ixekizumab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 8, 2017
Primary completion
May 25, 2020
Completion
May 26, 2021
Last update posted
Jun 12, 2022

2017 – 2021

United States locations

U.S. sites
23
U.S. states
18
U.S. cities
23
Facility City State ZIP Site status
Arizona Arthritis & Rheumatology Research Phoenix Arizona 85032
Care Access Research - Huntington Beach Huntington Beach California 92648
Desert Medical Advances Palm Desert California 92260
Arthritis Assoc. & Osteoporosis Ctr of Colorado Springs, LLC Colorado Springs Colorado 80920
Clinical Research Center of CT/NY Danbury Connecticut 06810
Arthritis Rheumatic Disease Specialties Aventura Florida 33180
Sarasota Arthritis Center Sarasota Florida 34239
Marietta Rheumatology Marietta Georgia 30060
Institute of Arthritis Research Idaho Falls Idaho 83404
Center for Arthritis & Osteoporosis Elizabethtown Kentucky 42701
Klein and Associates MD, PA Cumberland Maryland 21502
Klein and Associates MD, PA Hagerstown Maryland 21740
Arthritis Consultants Inc. St Louis Missouri 63141
Glacier View Research Institute Kalispell Montana 59901
Physician Research Collaboration, LLC Lincoln Nebraska 68516
Shanahan Rheumatology & Immunotherapy, PLLC Raleigh North Carolina 27617
Carolina Arthritis Associates Wilmington North Carolina 28401
Oregon Health and Science University Portland Oregon 97239
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Articularis Healthcare Group, INC dba Columbia Arthritis Ctr Columbia South Carolina 29204
Articularis Healthcare d/b/a/ Low Country Rheumatology, PA Summerville South Carolina 29486
Univ of Texas Health Science Center - Houston Houston Texas 77030
Arthritis Northwest PLLC Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 104 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03129100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 12, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03129100 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →